Cancer-Drug Discovery — Let's Get Ready for the Next Period
Author:
- Dan L. LongoDLDan L. Longo
- 4 December 2014
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 371 (23) , 2227-2228
Abstract
The use of drugs to treat cancer began about 70 years ago. After World War II, Louis Goodman and Alfred Gilman and their colleagues at Yale University noted that people who had been exposed to mustard gas often had bone marrow suppression. They identified the active chemical moiety in the gas, gave it to patients, and saw responses in patients with hematologic cancers.1 Thus, alkylating agents were developed and became key components of treatments for many forms of cancer.Not all useful drugs emerged as a product of accurate hypotheses. Sidney Farber mistakenly thought that leukemic cells looked megaloblastic, and . . .Keywords
This publication has 8 references indexed in Scilit:
- Ceritinib inALK-Rearranged Non–Small-Cell Lung CancerNew England Journal of Medicine, 2014
- Cancer Genome LandscapesScience, 2013
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with VemurafenibNew England Journal of Medicine, 2012
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948
- NITROGEN MUSTARD THERAPYJAMA, 1946